Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2019-04-01 Annual Report
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2018, submitted by KM Pharmaceutical Co., Ltd. to the Financial Services Commission and the Korea Exchange. It contains comprehensive financial information, company history, management details, and capital structure, which aligns with the definition of an Annual Report (10-K). FY 2018
2019-04-01 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'KM Pharmaceutical Co., Ltd.' (케이엠제약 주식회사). It contains detailed corporate information, including company history, capital changes, shareholding structure, and management details for the fiscal year 2018. In the South Korean regulatory context (DART system), the 'Business Report' is the equivalent of the US 10-K, serving as the comprehensive annual report. The document includes a 'Correction Report' (정정신고) header, which is a standard procedure for updating previously filed annual reports. FY 2018
2019-04-01 Korean
전환청구권행사(제1회차)
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds into shares. This type of corporate action involves changes to the company's capital structure and share issuance. According to the provided categories, 'Share Issue/Capital Change' (SHA) is the most appropriate classification for announcements regarding new share issues resulting from the conversion of debt instruments.
2019-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and board appointments. This matches the definition for a Declaration of Voting Results & Voting Rights Announcement (DVA).
2019-03-27 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2019-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by KM Pharmaceutical. It contains the auditor's opinion, key financial data (assets, liabilities, equity, profit/loss), and details regarding the audit process. While it provides financial data, it is a specific regulatory filing required by the KRX (Korea Exchange) to announce the completion and submission of the audit report, rather than the full 10-K annual report itself. Therefore, it falls under the category of Audit Report / Information. FY 2018
2019-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.